Rebamipide - 10mM in DMSO, high purity , CAS No.90098-04-7(DMSO)

Item Number

R408057

Grouped product items
SKU	Size	Availability	Price	Qty
R408057-1ml	1ml	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$49.90

CCK receptor Inhibitors

Basic Description

Specifications & Purity	Moligand™, 10mM in DMSO
Biochemical and Physiological Mechanisms	Rebamipide (OPC-12759) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [¹²⁵I]BH-CCK-8S with IC50 of 37.7 μM.
Storage Temp	Store at -80°C
Shipped In	Ice chest + Ice pads
Grade	Moligand™
Product Description	Information Rebamipide Rebamipide (OPC-12759) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [ 125 I]BH-CCK-8S with IC50 of 37.7 μM. In vitro In vivo Cell Data cell lines： Concentrations： Incubation Time： Powder Purity:≥99%

Canonical SMILES

OC(=O)C(CC1=CC(=O)NC2=C1C=CC=C2)NC(=O)C3=CC=C(Cl)C=C3

Molecular Weight

370.79

Citations of This Product

1. Han Qiao, Zhuo Xu, Mengchi Sun, Shuwen Fu, Fangxue Zhao, Danping Wang, Zhonggui He, Yinglei Zhai, Jin Sun. (2022) Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 75 (103654). [PMID:] [10.1016/j.jddst.2022.103654]

References

1. Han Qiao, Zhuo Xu, Mengchi Sun, Shuwen Fu, Fangxue Zhao, Danping Wang, Zhonggui He, Yinglei Zhai, Jin Sun. (2022) Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 75 (103654). [PMID:] [10.1016/j.jddst.2022.103654]

Solution Calculators

Determine the necessary mass, volume, or concentration for preparing a solution.

Determine the dilution needed to prepare a stock solution.

Basic Description